Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02391909 · ClinicalTrials.gov registry record
Phase 4 Study To Assess The Safety Of Vivotif At Different Release Titers Among Travelers
A clinical trial, sponsored by Bavarian Nordic.
- Completed
- Registry status
- 855
- Enrollment target
NCT02391909 is a clinical trial that has completed, run by Bavarian Nordic. The registered enrollment target is 855 participants.
The verdict
NCT02391909 has completed, sponsored by Bavarian Nordic.
- COMPLETED
- Registry status
- 855 participants
- Enrollment target
Study Summary
This is a multicenter (at travel clinics), phase 4 observational prospective cohort study in healthy adult male and female travelers for whom typhoid vaccination with Vivotif is recommended, as per standard practice.
Interventions
- BIOLOGICAL Vivotif
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 855 participants |
| Start Date | 2015-08-26 |
| Est. Completion | 2017-02-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02391909
The ClinicalTrials.gov registry entry for NCT02391909 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 855 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bavarian Nordic, which has 41 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vivotif is the first listed.
NCT02391909 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02391909 about?
NCT02391909 is a clinical study titled "Phase 4 Study To Assess The Safety Of Vivotif At Different Release Titers Among Travelers". This is a multicenter (at travel clinics), phase 4 observational prospective cohort study in healthy adult male and female travelers for whom typhoid vaccination with Vivotif is recommended, as per standard practice.
What is the current status of trial NCT02391909?
This trial is currently completed. The enrollment target is 855 participants. The study started on 2015-08-26. Estimated completion is 2017-02-21.
What interventions are being tested in trial NCT02391909?
The interventions under investigation include: Vivotif (BIOLOGICAL).
Who is sponsoring clinical trial NCT02391909?
This trial is sponsored by Bavarian Nordic, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.